| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/04/2004 | EP1386927A1 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| 02/04/2004 | EP1386639A1 Use of 78 genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386616A1 Antibordetella vaccine |
| 02/04/2004 | EP1386167A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 02/04/2004 | EP1386157A2 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors |
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1385995A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 02/04/2004 | EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 02/04/2004 | EP1385987A2 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof |
| 02/04/2004 | EP1385979A2 Method for enhancing the translation and expression of recombinant proteins |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385968A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants |
| 02/04/2004 | EP1385967A2 Non aggregating fluorescent proteins and methods for using the same |
| 02/04/2004 | EP1385966A2 Recombinant fusion proteins and the trimers thereof |
| 02/04/2004 | EP1385960A2 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour |
| 02/04/2004 | EP1385958A2 Human tachykinin-related splice variants and compositions thereof |
| 02/04/2004 | EP1385956A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/04/2004 | EP1385955A2 Cell adhesion proteins |
| 02/04/2004 | EP1385954A2 Proteins associated with cell growth, differentiation, and death |
| 02/04/2004 | EP1385953A2 Proteins and nucleic acids encoding same |
| 02/04/2004 | EP1385947A1 Compositions and methods to control bleeding |
| 02/04/2004 | EP1385946A2 A system for inducible expression in eukaryotic cells |
| 02/04/2004 | EP1385945A1 Novel mutation |
| 02/04/2004 | EP1385942A2 Regulation of target protein activity through modifier proteins |
| 02/04/2004 | EP1385939A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 02/04/2004 | EP1385935A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 02/04/2004 | EP1385887A1 Repressors for hiv transcription and methods thereof |
| 02/04/2004 | EP1385885A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the ligand binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 02/04/2004 | EP1385884A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385881A1 Anti-obesity polypeptides |
| 02/04/2004 | EP1385880A2 Use of binding domains of presenilins for drug screening |
| 02/04/2004 | EP1385879A1 Reproductive cancer diagnosis and therapy |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385877A2 Polypeptides |
| 02/04/2004 | EP1385876A2 Gonococcal proteins and nucleic acids |
| 02/04/2004 | EP1385875A2 Epitopes of virus hepatitis c specifically cd4+ t-lymphocytes |
| 02/04/2004 | EP1385874A1 Alpha conotoxin peptides with analgesic properties |
| 02/04/2004 | EP1385873A2 A ligand for enhancing oral and cns delivery of biological agents |
| 02/04/2004 | EP1385872A1 Inhibitors of receptor activator of nf-kappa b and uses thereof |
| 02/04/2004 | EP1385871A1 Process for inactivating prions in lipoproteins |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385862A2 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385861A2 Compositions and methods relating to lung specific genes and proteins |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385554A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 02/04/2004 | EP1385542A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 02/04/2004 | EP1385538A2 Chimeric vaccines |
| 02/04/2004 | EP1385534A2 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 02/04/2004 | EP1385533A1 Module of pd-1 interactions with its ligands |
| 02/04/2004 | EP1385532A1 Stimulation of osteogenesis using rank ligand fusion proteins |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385381A2 Human secreted proteins |
| 02/04/2004 | EP1385380A2 Human secreted proteins |
| 02/04/2004 | EP1385370A2 Animicrobial polypeptides and their uses |
| 02/04/2004 | EP0975954B1 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules |
| 02/04/2004 | EP0938578B1 Genetic modification of primate hemopoietic repopulating stem cells |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0842287B1 High efficiency helper system for aav vector production |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | EP0777731B1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 02/04/2004 | EP0745386B1 Anti-aids secretory recombinant bcg vaccine |
| 02/04/2004 | EP0698094B1 Bmp-11 compositions |
| 02/04/2004 | EP0670848B1 High molecular weight collagen-like protein polymers |
| 02/04/2004 | EP0642507B1 Transition state analogues of cocaine, their use for producing catalytic antibodies against cocaine and use of the same in diagnosis and therapy |
| 02/04/2004 | CN2602031Y Device for preparing high absorbance phycoerythrobilin using pink columnar mastoid alga |
| 02/04/2004 | CN1473195A Identification and characterization of anthocyanin mutant (ANT1) in tomato |
| 02/04/2004 | CN1473166A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 02/04/2004 | CN1472321A Chemosynthesized SARS virus S gene segement, its expression and application |
| 02/04/2004 | CN1472320A Chinese cabbage BcpFLC3 protein encoding array |
| 02/04/2004 | CN1472318A Expression and purification of soluble SARS virus nucleocapsid protein |
| 02/04/2004 | CN1472314A Immunity expression of AIDS virus O and its use |
| 02/04/2004 | CN1472225A Purifying method for recombination human leukopenic-1 receptor antagonist |
| 02/04/2004 | CN1472224A Holothurian extracts with anti-cancer activity and their preparation and use |
| 02/04/2004 | CN1472223A bZIP transcription factor of corn and its encoding genes and use |
| 02/04/2004 | CN1472222A DREB transcription factor of corn and its encoding genes and use |
| 02/04/2004 | CN1472221A Method for purifying teicoplanin by analog moving bed chromospheric separation |
| 02/04/2004 | CN1472219A Recombined human parathyroid hormone gene, its expression carrier and preparing method of recombined human parathyroid protein |
| 02/04/2004 | CN1137383C Human RTN 4B protein and code sequence and its preparation and use |
| 02/04/2004 | CN1137263C ATP sensitive potassium channel gene defective animal tissues and cells |
| 02/04/2004 | CN1137262C Mutants of Rb and P53 genes and uses thereof |
| 02/04/2004 | CN1137139C Process for producing recombined lymphotoxin derivative |
| 02/04/2004 | CN1137137C Insecticidal protein toxins from xenorhabdus |
| 02/04/2004 | CN1136920C Gene transfer-mediated angiogenesis therapy |
| 02/04/2004 | CN1136916C Long-acting injection suspensions and process for their preparation |
| 02/04/2004 | CN1136914C Method for identifying or isolating molecule and molecules identified therby |
| 02/03/2004 | US6686769 Programmable I/O element circuit for high speed logic devices |
| 02/03/2004 | US6686515 Homologous recombination in plants |
| 02/03/2004 | US6686513 Ubi9=(poly)ubiquitin gene promoter; genetic engineering; cloning; transgenes; polyubiquitin nucleotide sequence useful in regulating expression of other nucleic acid sequences of interest in monocotyledonous and dicotyledonous plants |
| 02/03/2004 | US6686456 Removal of kunitz, bowman-birk and carboxypeptidase inhibitors from plant extract; gnerate plant extract, heat, cool, remove denatured protein, filter the purified extract to remove the carboxypeptidase and bowman-birk inhibitors |
| 02/03/2004 | US6686455 Tumor necrosis factor |
| 02/03/2004 | US6686452 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP |
| 02/03/2004 | US6686450 Immunosuppressive agents that inhibit calcineurin function and uses of these agents |
| 02/03/2004 | US6686449 Mutant presenilin 1 polypeptides |
| 02/03/2004 | US6686448 Class II cytokine receptor-7 |
| 02/03/2004 | US6686447 Use of polynucleotides encoding polypeptides that comprise at least a portion of a lung tumor protein combined with physio-logical acceptable carrier providing immunogenic compositions /vaccine for prophylactic/therapeutic use against lung cancer |
| 02/03/2004 | US6686444 Osteopontin derived chemotactic peptides and methods of use |
| 02/03/2004 | US6686442 Peptide nucleic acid for use in veterinary medicine |